The 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, and virtually, from 9 - 12 June 2022, saw leading experts from around the world gather to discuss the most exciting updates in the field of hematology. Key updates on CAR-T therapy, transplant research, novel drugs, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalassemia, and beyond.  
View all videos

EHA 2022

EHA 2022
09–12 June 2022 | Vienna Austria / Online

Last week, we had the pleasure of being in Munich at #ISAL2023, interviewing experts in AML and ALL, who shared some interesting insights & updates.

Check out our interviews here:

🎥: http://ow.ly/xjOL50MWU55

#AMLsm #ALLsm #LeuSM #ImmunoOnc #HemOnc #ISALXVIII

#ISAL2023 | @RaviMajetiMD of @Stanford shares some insights into how epigenetic analysis may be used to better understand the biology of relapse in patients with AML.

Watch here:

👉http://ow.ly/aqBN50Nr42B👈

#AMLsm #LeuSM #HemOnc

#MyelomaAwarenessMonth is a great opportunity to discover the latest updates in myeloma.

For more, listen to our podcasts which cover a range of topics, including the role of MRD, immunotherapeutic approaches in myeloma, and more!

🎧: http://ow.ly/J5mT50N8kgr

#MMsm #HemOnc

Load More...

EHA 2022

EHA 2022
09–12 June 2022 | Vienna Austria / Online
The 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, and virtually, from 9 - 12 June 2022, saw leading experts from around the world gather to discuss the most exciting updates in the field of hematology. Key updates on CAR-T therapy, transplant research, novel drugs, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalassemia, and beyond.  
View all videos

Last week, we had the pleasure of being in Munich at #ISAL2023, interviewing experts in AML and ALL, who shared some interesting insights & updates.

Check out our interviews here:

🎥: http://ow.ly/xjOL50MWU55

#AMLsm #ALLsm #LeuSM #ImmunoOnc #HemOnc #ISALXVIII

#ISAL2023 | @RaviMajetiMD of @Stanford shares some insights into how epigenetic analysis may be used to better understand the biology of relapse in patients with AML.

Watch here:

👉http://ow.ly/aqBN50Nr42B👈

#AMLsm #LeuSM #HemOnc

#MyelomaAwarenessMonth is a great opportunity to discover the latest updates in myeloma.

For more, listen to our podcasts which cover a range of topics, including the role of MRD, immunotherapeutic approaches in myeloma, and more!

🎧: http://ow.ly/J5mT50N8kgr

#MMsm #HemOnc

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter